ArticleBJU international2020

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer.

Francesco Montorsi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.